Document Detail


Medications and associated symptoms/problems after coronary artery bypass surgery.
MedLine Citation:
PMID:  20561878     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this secondary analysis was to describe medication use and examine the relationship between medications and postoperative symptoms/problems in the first 3 months after coronary artery bypass surgery (CABS).
METHODS: The sample consisted of older (≥65 years) men and women (n = 232) who had undergone CABS. Medication data were collected through self-report 3 and 6 weeks and 3 months after surgery.
RESULTS: Most patients reported taking aspirin (88.2%-85.7%), statins or cholesterol-lowering drugs (88.6%-87%), and beta-blockers (68%-55.6%). No significant differences were found between the proportion of patients taking and not taking beta-blockers, antiarrhythmics, cholesterol-lowering drugs, or angiotensin-converting enzyme inhibitor medications for common medication-specific symptoms/problems.
CONCLUSION: Patients experience symptoms after surgery, but these symptoms did not seem to be side effects from medications. Nursing assessments and interventions targeting postoperative symptoms, symptom management, and medication side effects can enhance recovery and reinforce medication adherence.
Authors:
Paula Schulz; Donna J Lottman; Travis L Barkmeier; Lani Zimmerman; Sue Barnason; Melody Hertzog
Related Documents :
10826468 - Suicidal ideation and suicide attempts in general medical illnesses.
1813918 - Intracanal medications and antibiotics in the control of interappointment flare-ups.
20124428 - The mmpi-2 symptom validity scale (fbs) not influenced by medical impairment: a large s...
2911548 - Muscarinic poisoning from medications and mushrooms. a puzzling symptom complex.
8278358 - Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric iga.
18997208 - Value-based purchasing for medical devices.
Publication Detail:
Type:  Journal Article     Date:  2010-05-04
Journal Detail:
Title:  Heart & lung : the journal of critical care     Volume:  40     ISSN:  1527-3288     ISO Abbreviation:  Heart Lung     Publication Date:    2011 Mar-Apr
Date Detail:
Created Date:  2011-03-14     Completed Date:  2011-07-21     Revised Date:  2012-03-08    
Medline Journal Info:
Nlm Unique ID:  0330057     Medline TA:  Heart Lung     Country:  United States    
Other Details:
Languages:  eng     Pagination:  130-8     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
UNMC College of Nursing-Lincoln Division, Lincoln, Nebraska 68588-0220, USA. pschulz@unmc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / adverse effects,  therapeutic use
Aged
Angiotensin-Converting Enzyme Inhibitors / adverse effects,  therapeutic use
Anti-Arrhythmia Agents / adverse effects,  therapeutic use
Anticholesteremic Agents / adverse effects,  therapeutic use
Aspirin / adverse effects,  therapeutic use
Calcium Channel Blockers / adverse effects,  therapeutic use
Coronary Artery Bypass / adverse effects*
Female
Humans
Male
Platelet Aggregation Inhibitors / adverse effects,  therapeutic use
Postoperative Complications / prevention & control*
Risk Factors
Self Report
Statistics as Topic
Grant Support
ID/Acronym/Agency:
R01 NR007759-05/NR/NINR NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Arrhythmia Agents; 0/Anticholesteremic Agents; 0/Calcium Channel Blockers; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Wash and wean: bathing patients undergoing weaning trials during prolonged mechanical ventilation.
Next Document:  The association between bathing and weaning trial duration.